FibroGen Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By: ChinaBio® Today
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.
In this article: AZN, LLY, FGEN
Read
5 Strong Stocks Analysts Are Upgrading Now
Article By: TipRanks
Wednesday, May 23, 2018 2:25 PM EDT
Why is the sentiment now shifting for these five stocks (FGEN, LRCX, ENR, FB and CACI)? Could it be that the market is looking more optimistic?
In this article: CACI, ENR, LRCX, FB, FGEN
Read
Week In Review: WuXi AppTec Acquires US-Global Clinical CRO
Article By: ChinaBio® Today
Saturday, October 21, 2017 5:25 PM EDT
WuXi AppTec, China's largest CRO/CMO, will acquire a global clinical-stage contract research company, ResearchPoint Global, of Austin,Texas. WuXi said the acquisition would extend its CRO network around the world.
In this article: AZN, HCM, RVX, FGEN
Read
FibroGen, Inc. Shares Shoot Up On Positive Results From Phase 2 Study Of Pamrevlumab
Article By: TickerTV
Tuesday, August 8, 2017 10:46 AM EDT
FGEN opened trading yesterday at $34.90 which was down from the previous day’s trading close of $35.00. FGEN closed trading yesterday at $33.40 and spiked up after hours to $53.95, equivalent to a 62% increase from the closing price.
In this article: FGEN
Read
FibroGen, Inc. Announces Pricing Of Follow-On Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, April 6, 2017 12:56 PM EDT
FibroGen is offering 5,228,750 shares of its common stock at an offering price of $22.95 per share, before underwriting discounts and commissions.
In this article: FGEN
Read

PARTNER HEADLINES

Latest Tweets for $FGEN

No tweets yet!